CurrentRheuma coverage · page 38 of 48
Rheumatology (Oxford)
Latest from Rheumatology (Oxford)
Rheumatology (Oxford)
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
Secondary analysisSystemic sclerosis
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Cardiovascular risk in myositis patients compared with the general population
Case-control studyMyositis
Rheumatology (Oxford)
Rheumatology (Oxford)
A nomogram based on clinical factors and CT radiomics for predicting anti-MDA5+ DM complicated by RP-ILD
Diagnostic or prognostic studyMyositis
Rheumatology (Oxford)
Rheumatology (Oxford)
Immune-mediated diseases and risk of incident cardiovascular diseases: a prospective cohort study
Cohort studyAcross diseases
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Exclusion of older adults from randomized controlled trials in rheumatoid arthritis
Cross-sectional studyRA
Rheumatology (Oxford)
ANCA-associated scleritis: impact of ANCA on presentation, response to therapy and outcome
Case-control studyVasculitis & PMR
Rheumatology (Oxford)
How to treat VEXAS syndrome: a systematic review on effectiveness and safety of current treatment strategies
Meta-analysisAutoinflammatory & rare
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Targeted testing of bone marrow specimens with cytoplasmic vacuolization to identify previously undiagnosed cases of VEXAS syndrome
Diagnostic or prognostic studyAutoinflammatory & rare
Rheumatology (Oxford)
A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry
Diagnostic or prognostic studyPediatric
Rheumatology (Oxford)
Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2
Cross-sectional studyAcross diseases
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades
Cohort studySystemic sclerosis
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Venous and arterial thromboembolic risk of Janus kinase inhibitors: a systematic review with meta-analysis
Meta-analysisAcross diseases
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Diagnostic delay is associated with uveitis and inflammatory bowel disease in AS: a study of extra-musculoskeletal manifestations in SpA
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)
Serum level of galectin-9 as a potential biomarker for high risk of malignancy in dermatomyositis
Cross-sectional studyMyositis